By contrast, transcript-level silencing of YAP1 and WWTR1 has been reported in hematological cancers such as multiple myeloma (MM) (28, 29) and NE cancers such as medullary thyroid cancer (30–32), NE prostate cancer (33), and small cell lung cancer (SCLC) (34–37). This evidence concerns the gene YAP1 and prostate cancer.